bioMérieux Showcases Advanced Generation of VIDAS Immunoassay Solution
Posted on 05 Feb 2024
bioMérieux (Marcy l'Etoile, France) is participating in Medlab Middle East 2024 as a Diamond Partner where the company is sharing its game-changing innovations. Visitors to the bioMérieux booth can discover, and exchange insights on antimicrobial stewardship, sepsis management, point-of-care solutions, and emergency care, among others.
At Medlab Middle East 2024, bioMérieux is presenting its recently launched VIDAS KUBE, the advanced generation of its VIDAS immunoassay solution which has been trusted by labs around the world for more than 30 years. VIDAS has transformed the field of immunoassays offering laboratories universal access to a simple, automated, and robust technology providing fast and reliable results. Featuring a single-test concept in an all-in-one kit, VIDAS is currently used in more than 160 countries by 25,000 laboratories. It is still one of the most widely used immunoassay systems in clinical laboratories worldwide. VIDAS KUBE, the latest addition to this innovative range, combines advanced technology with the recognized values of the VIDAS solution. The new VIDAS KUBE features a stackable and modular benchtop design and easy implementation that will benefit clinical diagnostic labs. It is compatible with the existing broad routine test menu covering emergency and critical care, immunochemistry, and infectious diseases.
In addition, bioMérieux is showcasing VITEK MS PRIME, a next-level automated MALDI-TOF Mass Spectrometry system that enables accurate microbial identification to the species level. This benchtop high-throughput automated identification system has a robust database, which includes intra-species diversity, and delivers fast and confident microbial identification. The system has the features required to ensure compliance, and you can rely on our validation experts to implement this solution quickly and efficiently. bioMérieux is also highlighting the VITEK REVEAL rapid Antimicrobial Susceptibility Testing, integrated into its Sepsis Solution to help better manage bloodstream infections. Among its point-of-care diagnostic solutions, bioMérieux is highlighting the BIOFIRE SPOTFIRE System which is the latest advancement in molecular infectious disease diagnostics. All of the company’s expertise and cutting-edge FILMARRAY technology are at the heart of the system design. Within its point-of-care respiratory testing solutions, bioMérieux is spotlighting the BIOFIRE SPOTFIRE Respiratory Panels which offer rapid syndromic PCR tests for a range of common pathogens.
Related Links:
bioMérieux
